Skip to content
Indiatimes Hosting

Home

Category: Biotech ResearchSyndicate content

Extended Suboxone Treatment Substantially Improves Outcomes for Opioid-Addicted Young Adults

November 6, 2008 by vikas

vikas's picture
0
No votes yet
Your rating: None

In the first clinical trial of a medication that was used for an extended time to treat opioid addiction in young adults, participants who received counseling and Suboxone (buprenorphine-naloxone) for 12 weeks had substantially better outcomes than those who received the standard treatment of short-term detoxification and counseling.

  • Login or register to post comments
  • Read more
  • 24 reads

New and Better Anti-AIDS drug

October 27, 2008 by craig

craig's picture

Washington: In a study of phase III clinical trials of a new anti-AIDS drug showed a decreased spread of HIV. The new drug ISENTRESS® reduced HIV viral load to undetectable levels in 86 percent of patients compared to 82 percent of patients treated with efavirenz(former product of MERC) in previously untreated HIV patients.

  • craig's blog
  • Login or register to post comments
  • Read more
  • 39 reads

LIPID PARTICLES AS ADJUVANTS AND DELIVERY SYSTEMS

October 11, 2008 by craig

craig's picture

Liposomes have been used to deliver vaccines and have been observed to have immunostimulant activity. When administered orally liposomes with encapsulated antigens have been claimed to provide protection from the gastric proteolytic enzymes.

  • craig's blog
  • Login or register to post comments
  • Read more
  • 13 reads

THE FUTURE OF VACCINES AND VACCINATION

October 11, 2008 by craig

craig's picture

It is evident that currently vaccine research is a vigorous and developing topic but a number of goals remain elusive. For example, an ideal vaccine should elicit the required immunological response against specified pathogens, whether it requires a specialized delivery system or adjuvants. This entails comparison of the requirements for an ideal vaccine, with progress to date.

  • craig's blog
  • Login or register to post comments
  • Read more
  • 18 reads

Biotech brings relief to the Diabetic patients

October 11, 2008 by craig

craig's picture
0
No votes yet
Your rating: None

Diabetes patients can soon forget the painful daily shots of insulin. Biotechnology company Shreya Lifesciences has got into in-licensing agreement with US-based Generex Biotechnology Corp to market Oral-lyn, the country’s first needle-free insulin.

  • Login or register to post comments
  • Read more
  • 40 reads

Latest Biotech Discussions

Archive Syndicate content
AdaptiveThemes